Aviva’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Sell
25,153
-553
-2% -$23.8K ﹤0.01% 637
2025
Q4
$1.13M Sell
25,706
-1,154
-4% -$47.7K ﹤0.01% 657
2025
Q3
$1.11M Buy
26,860
+3,617
+16% +$145K ﹤0.01% 655
2025
Q2
$1.02M Buy
23,243
+7,105
+44% +$284K ﹤0.01% 659
2025
Q1
$596K Sell
16,138
-1,090
-6% -$38.8K ﹤0.01% 712
2024
Q4
$574K Sell
17,228
-7,699
-31% -$250K ﹤0.01% 749
2024
Q3
$647K Buy
+24,927
New +$620K ﹤0.01% 757
2021
Q2
Sell
-54,461
Closed -$1.23M 903
2021
Q1
$1.23M Buy
54,461
+5,282
+11% +$119K 0.01% 797
2020
Q4
$987K Sell
49,179
-39,868
-45% -$835K 0.01% 864
2020
Q3
$2.18M Sell
89,047
-11,431
-11% -$267K 0.01% 757
2020
Q2
$2.38M Sell
100,478
-110,340
-52% -$2.56M 0.01% 593
2020
Q1
$3.63M Buy
210,818
+96,109
+84% +$1.76M 0.03% 568
2019
Q4
$2.02M Buy
+114,709
New +$1.94M 0.01% 700

Other funds holding EXEL